The global obesity epidemic is well established, with increases in obesity prevalence for most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk factors, ...

ALEXANDRIA, Va. — A large observational study of more than 170,000 patients with diabetes and obesity in the United States has found that GLP-1 receptor agonists may modestly reduce the risk of ...

Colonic inflammation explains missing link between obesity and beta-cell proliferation Date: May 9, 2025 Source: Tohoku University Summary: How does obesity affect insulin production? Researchers ...

This guideline covers the prevention and management of overweight, obesity and central adiposity in children, young people and adults. It brings together and updates all NICE's previous guidelines on ...

On Jan 14, 2025, The Lancet Diabetes & Endocrinology published its Commission on the definition and diagnostic criteria of clinical obesity. Acknowledging the obstacles and knowledge gaps in the field ...

Two couples in California discovered they were raising each other’s genetic children. Should they switch their girls?

The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion, according to a global analysis published in The Lancet. These trends, together with ...

Obesity is a chronic medical condition caused by excess visceral fat. It could raise your risk of developing multiple health conditions. Here's what you need to know.

The positions in the table below reflect the Nederlandse Obesitas Kliniek's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...